February 2018
Volume 72 | Number 1
Content
Inflammatory bowel disease
Can we increase the e ffectiveness of anti-TNF therapy?
EditorialGastroent Hepatol 2018; 72(1): 6–7.
Literaturepdf Martin BortlíkYoung woman with an expansive process in the right hypogastry
QuizGastroent Hepatol 2018; 72(1): 8–9.
pdf Milan LukášQuality of life in patients with inflammatory bowel diseases in the Czech Republic – a multicentre study
Original articleGastroent Hepatol 2018; 72(1): 11–19. doi:10.14735/amgh201811
SummaryLiteraturepdf Dana Ďuricová, Martina Pfeiferová, Martin Bortlík, Barbora Pipek, Ivana Mikoviny Kajzrlíková, Karel Dušek, Milan Lukáš, Pacientská organizace Pacienti IBDPregnancy outcomes in women with inflammatory bowel disease treated with biosimilar infliximab
Original articleGastroent Hepatol 2018; 72(1): 20–26. doi:10.14735/amgh201820
SummaryLiteraturepdf Martin Kolář, Martin Bortlík, Dana Ďuricová, Martin Lukáš, Veronika Hrubá, Naděžda Machková, Karin Malíčková, Milan LukášGuidelines of the IBD working group of the Slovak Society of Gastroenterology on the management of Crohn’s disease
GuidelinesGastroent Hepatol 2018; 72(1): 27–40. doi:10.14735/amgh201827
Literaturepdf Tomáš Koller, Jozef Tóth, Tibor Hlavatý, Mária Zakuciová, Anna Krajčovičová, Miloš Greguš, Jozef Baláž, Igor Šturdík, Martin Huorka, Pracovná skupina pre IBD SGSTherapeutic drug monitoring in the treatment of inflammatory bowel disease with infliximab
Review articleGastroent Hepatol 2018; 72(1): 41–46. doi:10.14735/amgh201841
SummaryLiteraturepdf Yashar Jalali, Anna Krajčovičová, Tibor HlavatýEfficacy of ustekinumab in a patient refractory to other biological treatment
Case reportGastroent Hepatol 2018; 72(1): 47–49. doi:10.14735/amgh201847
SummaryLiteraturepdf Martin Bortlík, Naděžda Machková, Veronika Hrubá, Martin Lukáš, Dana Ďuricová, Karin Malíčková, Zuzana Šerclová, Milan LukášChapters from internal medicine
Gastroenterology and renal diseases
Review articleGastroent Hepatol 2018; 72(1): 50–57. doi:10.14735/amgh201850
SummaryLiteraturepdf Vladimír Teplan, Olga Marečková, Milan LukášA comparison of cost-effectiveness analysis of two strategies – immediate and delayed initiation of treatment of hepatitis C in the Czech Republic
Original articleGastroent Hepatol 2018; 72(1): 58–65. doi:10.14735/amgh201858
SummaryLiteraturepdf Jana Skoupá, Petr UrbánekThe role of CT colonography in large bowel investigation
Original articleGastroent Hepatol 2018; 72(1): 66–72. doi:10.14735/amgh201866
SummaryLiteraturepdf Hana Straková, Ludvík StrakaEndoscopic treatment of Bouveret syndrome
Case reportGastroent Hepatol 2018; 72(1): 73–76. doi:10.14735/amgh201873
SummaryLiteraturepdf Nageeb Ghaleb, Petr FojtíkIn memoriam: Assoc. Prof. Zdenek Slezak, CSc.
Personal newsGastroent Hepatol 2018; 72(1): 77.
pdf František ChaloupkaThe selection from international journals
CommentsGastroent Hepatol 2018; 72(1): 78–81.
pdf Irena Míková, Vincent Zoundjiekpon, Michal Štěpán, Eva Evinová, Martin Kolář, Tomáš GregaAnswer to the quiz
Answer to the quizGastroent Hepatol 2018; 72(1): 85–86.
Literaturepdf Milan LukášVSL#3 – the first highly concentrated therapeutic probiotic with multiple bacterial strains and a proven therapeutic efficacy
Drug profileGastroent Hepatol 2018; 72(1): 85–86. doi:10.14735/amgh201885
Literaturepdf Luděk Hrdlička